Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Anomalies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02837640
What this trial is testing

Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Beirut Eye Specialist Hospital 50
Not applicableWithdrawnNCT02548572
What this trial is testing

Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study

Who this might be right for
Retinitis Pigmentosa
Wills Eye
Large-scale testing (Phase 3)Active Not RecruitingNCT06388200
What this trial is testing

OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Ocugen 140
Testing effectiveness (Phase 2)Study completedNCT00510965
What this trial is testing

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Choroidal Neovascularization
University Hospital, Bonn 10
Not applicableUnknownNCT04101604
What this trial is testing

Biomarkers of Common Eye Diseases

Who this might be right for
UveitisDiabetic RetinopathyAge-related Macular Degeneration+3 more
Sun Yat-sen University 220
Not applicableStudy completedNCT02759952
What this trial is testing

Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial

Who this might be right for
Retinitis Pigmentosa
STZ eyetrial 50
Not applicableStudy completedNCT00000989
What this trial is testing

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Looking for participantsNCT06787482
What this trial is testing

Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies

Who this might be right for
Retinitis Pigmentosa (RP)Age Related Macular DegenerationDiabetic Retinopathy
Ace Cells Lab Limited 100
Not applicableStudy completedNCT01256697
What this trial is testing

The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Sheba Medical Center 34
Large-scale testing (Phase 3)Ended earlyNCT01786395
What this trial is testing

Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
R-Tech Ueno, Ltd. 202
Testing effectiveness (Phase 2)Study completedNCT05282953
What this trial is testing

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)

Who this might be right for
Retinitis PigmentosaChoroideremiaNon-Syndromic Rod-Dominant Inherited Retinal Diseases
Kiora Pharmaceuticals, Inc. 32
Early research (Phase 1)Looking for participantsNCT05147701
What this trial is testing

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION

Who this might be right for
Eye DiseasesRetinitis PigmentosaDiabetic Retinopathy+3 more
The Foundation for Orthopaedics and Regenerative Medicine 20
Not applicableStudy completedNCT02887157
What this trial is testing

Analyzing Retinal Microanatomy in ROP

Who this might be right for
Retinopathy of PrematurityNeurodevelopmental DisordersMacular Edema
Duke University 191
Testing effectiveness (Phase 2)Looking for participantsNCT06789445
What this trial is testing

Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Who this might be right for
Primary Photoreceptor DiseaseRetinitis Pigmentosa (RP)Usher Syndrome+6 more
BlueRock Therapeutics 54
Not applicableStudy completedNCT00004827
What this trial is testing

Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Retina Foundation of the Southwest 46
Not applicableStudy completedNCT01054027
What this trial is testing

Study on Effective Mydriasis in Premature Infants

Who this might be right for
Retinopathy of Prematurity (ROP)
Georgetown University 15
Testing effectiveness (Phase 2)Study completedNCT04315025
What this trial is testing

Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
PT. Prodia Stem Cell Indonesia 18
Not applicableUnknownNCT04773561
What this trial is testing

Comparison of Posterior Ocular Changes Between Singleton Pregnancy and Multifetal Pregnancy.

Who this might be right for
Twin Pregnancy, Antepartum Condition or ComplicationRetinal VascularChoroidal Effusion
Khon Kaen University 166
Not applicableLooking for participantsNCT07502664
What this trial is testing

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)

Who this might be right for
Retinitis PigmentosaStargardt Macular DystrophyStargardt Disease+3 more
Ray Therapeutics, Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT07439887
What this trial is testing

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

Who this might be right for
Stargardt Disease
Ray Therapeutics, Inc. 18
Next Page